Doug Hubatsch
Tracked across 2 events · 13 articles · First seen Jun 18, 2026 · Last active Sep 02, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Doug Hubatsch transitioned to Chief Scientific Advisor, continuing to support NCX 470 through regulatory review. His leadership in development is acknowledged.
Sep 02, 2026 · 6 articles
Business
Impact: Doug Hubatsch, Chief Scientific Officer of NicOx, expressed confidence in the upcoming NDA submissions for NCX 470 in both the U.S. and China.
Jun 18, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Doug Hubatsch live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard